{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:55:42Z","timestamp":1791896142258,"version":"4.3.4"},"reference-count":106,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.drudis.2024.104138","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T16:16:16Z","timestamp":1724084176000},"page":"104138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Preclinical alternative drug discovery programs for monogenic rare diseases. Should small molecules or gene therapy be used? The case of hereditary spastic paraplegias"],"prefix":"10.1016","volume":"29","author":[{"given":"Matteo Rossi","family":"Sebastiano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Hadano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizia","family":"Cesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Lamacchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Brusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verdiana","family":"Pullano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Baj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Gurgone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Chiantia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Giustetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna J.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"van Putte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Della Vecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Battini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Maria Santorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ermondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2024.104138_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.914338","article-title":"Valuing the \u201cburden\u201d and impact of rare diseases: a scoping review","volume":"13","author":"Delaye","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2024.104138_b0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13073-022-01026-w","article-title":"A guide for the diagnosis of rare and undiagnosed disease: beyond the exome","volume":"14","author":"Marwaha","year":"2022","journal-title":"Genome Med"},{"key":"10.1016\/j.drudis.2024.104138_b0015","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.fmre.2022.09.002","article-title":"Rare and undiagnosed diseases: from disease-causing gene identification to mechanism elucidation","volume":"2","author":"Wang","year":"2002","journal-title":"Fundam Res"},{"key":"10.1016\/j.drudis.2024.104138_b0020","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.drudis.2022.01.013","article-title":"Drug repositioning trends in rare and intractable diseases","volume":"27","author":"Sakate","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2024.104138_b0025","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.drudis.2021.10.014","article-title":"Knowledge-based approaches to drug discovery for rare diseases","volume":"27","author":"Alves","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2024.104138_b0030","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.drudis.2013.08.006","article-title":"Multifaceted roles of ultra-rare and rare disease patients\/parents in drug discovery","volume":"18","author":"Wood","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2024.104138_b0035","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S1474-4422(19)30235-2","article-title":"Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches","volume":"18","author":"Shribman","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.drudis.2024.104138_b0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10048-018-0545-9","article-title":"The impact of next-generation sequencing on the diagnosis of pediatric-onset hereditary spastic paraplegias: new genotype-phenotype correlations for rare HSP-related genes","volume":"19","author":"Travaglini","year":"2018","journal-title":"Neurogenetics"},{"key":"10.1016\/j.drudis.2024.104138_b0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrn2946","article-title":"Hereditary spastic paraplegias: membrane traffic and the motor pathway","volume":"12","author":"Blackstone","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.drudis.2024.104138_b0050","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.drudis.2017.11.002","article-title":"Rare genetic diseases: update on diagnosis, treatment and online resources","volume":"23","author":"Pogue","year":"2018","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2024.104138_b0055","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.3390\/molecules27207063","article-title":"Personalized treatment for infantile ascending hereditary spastic paralysis based on in silico strategies","volume":"27","author":"Rossi Sebastiano","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2024.104138_b0060","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejca.2017.09.007","article-title":"Bridging the gap between the randomised clinical trial world and the real world by combination of population-based registry and electronic health record data: a case study in haemato-oncology","volume":"86","author":"Kibbelaar","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.drudis.2024.104138_b0065","series-title":"Registries for evaluating patient outcomes: a user\u2019s guide. Third edition","year":"2014"},{"key":"10.1016\/j.drudis.2024.104138_b0070","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jval.2016.02.007","article-title":"Balancing the optimal and the feasible: a practical guide for setting up patient registries for the collection of real-world data for health care decision making based on Dutch experiences","volume":"20","author":"de Groot","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/j.drudis.2024.104138_b0075","first-page":"109","article-title":"Real-world data for clinical evidence generation in oncology","author":"Khozin","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.drudis.2024.104138_b0080","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.drudis.2024.104138_b0085","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2024.104138_b0090","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/s41431-021-00959-x","article-title":"The LOVD3 platform: efficient genome-wide sharing of genetic variants","volume":"29","author":"Fokkema","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.drudis.2024.104138_b0095","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","article-title":"The Human Gene Mutation Database (HGMD\u00ae): optimizing its use in a clinical diagnostic or research setting","volume":"139","author":"Stenson","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.drudis.2024.104138_b0100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2024.104138_b0105","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/humu.23626","article-title":"Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion","volume":"39","author":"Abou Tayoun","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.drudis.2024.104138_b0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.drudis.2024.104138_b0115","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2024.104138_b0120","doi-asserted-by":"crossref","first-page":"D886","DOI":"10.1093\/nar\/gky1016","article-title":"CADD: predicting the deleteriousness of variants throughout the human genome","volume":"47","author":"Rentzsch","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2024.104138_b0125","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/nar\/29.5.1185","article-title":"GeneSplicer: a new computational method for splice site prediction","volume":"29","author":"Pertea","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2024.104138_b0130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cmb.1997.4.311","article-title":"Improved splice site detection in Genie","volume":"4","author":"Reese","year":"1997","journal-title":"J Comput Biol"},{"key":"10.1016\/j.drudis.2024.104138_b0135","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","article-title":"VarSome: the human genomic variant search engine","volume":"35","author":"Kopanos","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2024.104138_b0140","first-page":"782","article-title":"Variant-level matching for diagnosis and discovery: challenges and opportunities","volume":"43","author":"Rodrigues","year":"2022","journal-title":"Hum Mutat"},{"key":"10.1016\/j.drudis.2024.104138_b0145","doi-asserted-by":"crossref","first-page":"D158","DOI":"10.1093\/nar\/gkw1099","article-title":"UniProt: the universal protein knowledgebase","volume":"45","author":"The UniProt Consortium","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2024.104138_b0150","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2024.104138_b0155","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejpn.2013.09.009","article-title":"Infantile-onset ascending hereditary spastic paralysis: a case report and brief literature review","volume":"18","author":"Racis","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.drudis.2024.104138_b0160","doi-asserted-by":"crossref","first-page":"e605","DOI":"10.1212\/NXG.0000000000000605","article-title":"Disease severity and motor impairment correlate with health-related quality of life in AP-4-associated hereditary spastic paraplegia","volume":"7","author":"Jordan","year":"2021","journal-title":"Neurol Genet"},{"key":"10.1016\/j.drudis.2024.104138_b0165","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/jmedgenet-2020-107003","article-title":"Assessing performance of pathogenicity predictors using clinically relevant variant datasets","volume":"58","author":"Gunning","year":"2021","journal-title":"J Med Genet"},{"key":"10.1016\/j.drudis.2024.104138_b0170","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.drudis.2022.02.008","article-title":"Defining clinical outcome pathways","volume":"27","author":"Korn","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2024.104138_b0175","doi-asserted-by":"crossref","first-page":"e164575","DOI":"10.1172\/JCI164575","article-title":"Intrathecal AAV9\/AP4M1 gene therapy for hereditary spastic paraplegia 50 shows safety and efficacy in preclinical studies","volume":"133","author":"Chen","year":"2023","journal-title":"J Clin Investigation"},{"key":"10.1016\/j.drudis.2024.104138_b0180","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41434-020-0174-4","article-title":"Large gene delivery to the retina with AAV vectors: are we there yet?","volume":"28","author":"Trapani","year":"2021","journal-title":"Gene Ther"},{"key":"10.1016\/j.drudis.2024.104138_b0185","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.tips.2021.01.003","article-title":"Drug repurposing for rare diseases","volume":"42","author":"Roessler","year":"2021","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.drudis.2024.104138_b0190","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/534314a","article-title":"Can you teach old drugs new tricks?","volume":"534","author":"Nosengo","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2024.104138_b0195","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jacbts.2019.02.005","article-title":"Phase II trials in drug development and adaptive trial design","volume":"4","author":"Van Norman","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.drudis.2024.104138_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103688","article-title":"Toward responsible clinical n-of-1 strategies for rare diseases","volume":"28","author":"Defelippe","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2024.104138_b0205","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/d41573-023-00168-9","article-title":"IRDiRC drug repurposing guidebook: making better use of existing drugs to tackle rare diseases","volume":"22","author":"Hechtelt Jonker","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2024.104138_b0210","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ceb.2004.03.003","article-title":"Nonsense-mediated mRNA decay: terminating erroneous gene expression","volume":"16","author":"Baker","year":"2004","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.drudis.2024.104138_b0215","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ajhg.2018.06.009","article-title":"Identifying genes whose mutant transcripts cause dominant disease traits by potential gain-of-function alleles","volume":"103","author":"Coban-Akdemir","year":"2018","journal-title":"Am J Human Genet"},{"key":"10.1016\/j.drudis.2024.104138_b0220","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.drudis.2024.104138_b0225","doi-asserted-by":"crossref","first-page":"W529","DOI":"10.1093\/nar\/gkq399","article-title":"ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids","volume":"38","author":"Ashkenazy","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2024.104138_b0230","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","article-title":"Highly accurate protein structure prediction for the human proteome","volume":"596","author":"Tunyasuvunakool","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2024.104138_b0235","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2024.104138_b0240","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.drudis.2021.12.018","article-title":"AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP\/Alsin","volume":"27","author":"Rossi Sebastiano","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2024.104138_b0245","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera \u2013 a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.drudis.2024.104138_b0250","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.str.2011.03.019","article-title":"A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions","volume":"19","author":"Shapovalov","year":"2011","journal-title":"Structure"},{"key":"10.1016\/j.drudis.2024.104138_b0255","doi-asserted-by":"crossref","first-page":"W350","DOI":"10.1093\/nar\/gky300","article-title":"DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability","volume":"46","author":"Rodrigues","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2024.104138_b0260","doi-asserted-by":"crossref","first-page":"W338","DOI":"10.1093\/nar\/gky356","article-title":"CABS-flex 2.0: a web server for fast simulations of flexibility of protein structures","volume":"46","author":"Kuriata","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2024.104138_b0265","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1021\/acs.jcim.1c00201","article-title":"Three simple properties explain protein stability change upon mutation","volume":"61","author":"Caldararu","year":"2021","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.drudis.2024.104138_b0270","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/bioinformatics\/btaa774","article-title":"The VEGA suite of programs: an versatile platform for cheminformatics and drug design projects","volume":"37","author":"Pedretti","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2024.104138_b0275","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ajhg.2022.12.007","article-title":"Deleterious, protein-altering variants in the transcriptional coregulator ZMYM3 in 27 individuals with a neurodevelopmental delay phenotype","volume":"110","author":"Hiatt","year":"2023","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.drudis.2024.104138_b0280","doi-asserted-by":"crossref","first-page":"189","DOI":"10.12688\/f1000research.7931.1","article-title":"FreeSASA: an open source C library for solvent accessible surface area calculations","volume":"5","author":"Mitternacht","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.drudis.2024.104138_b0285","doi-asserted-by":"crossref","first-page":"D259","DOI":"10.1093\/nar\/gkt1047","article-title":"The eukaryotic linear motif resource ELM: 10 years and counting","volume":"42","author":"Dinkel","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2024.104138_b0290","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/pro.3334","article-title":"Prediction of protein disorder based on IUPred","volume":"27","author":"Doszt\u00e1nyi","year":"2018","journal-title":"Protein Sci"},{"key":"10.1016\/j.drudis.2024.104138_b0295","doi-asserted-by":"crossref","first-page":"D808","DOI":"10.1093\/nar\/gks1094","article-title":"STRING v9.1: protein\u2013protein interaction networks, with increased coverage and integration","volume":"41","author":"Franceschini","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2024.104138_b0300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2024.104138_b0305","doi-asserted-by":"crossref","first-page":"D691","DOI":"10.1093\/nar\/gkq1018","article-title":"Reactome: a database of reactions, pathways and biological processes","volume":"39","author":"Croft","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2024.104138_b0310","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13321-015-0059-5","article-title":"Improving protein-ligand binding site prediction accuracy by classification of inner pocket points using local features","volume":"7","author":"Kriv\u00e1k","year":"2015","journal-title":"J Cheminform"},{"key":"10.1016\/j.drudis.2024.104138_b0315","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1471-2105-10-168","article-title":"Fpocket: an open source platform for ligand pocket detection","volume":"10","author":"Le Guilloux","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.drudis.2024.104138_b0320","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/bioinformatics\/bts310","article-title":"DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment","volume":"28","author":"Volkamer","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2024.104138_b0325","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2024.104138_b0330","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein-ligand docking using GOLD","volume":"52","author":"Verdonk","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.drudis.2024.104138_b0335","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1093\/bioinformatics\/btaa579","article-title":"Webina: an open-source library and web app that runs AutoDock Vina entirely in the web browser","volume":"36","author":"Kochnev","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2024.104138_b0340","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1074\/mcp.M800264-MCP200","article-title":"Antibodypedia, a portal for sharing antibody and antigen validation data","volume":"7","author":"Bj\u00f6rling","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.drudis.2024.104138_b0345","first-page":"2669","article-title":"Patient-derived skin fibroblasts as a model to study frontotemporal lobar degeneration","volume":"17","author":"Hoffmann","year":"2002","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.drudis.2024.104138_b0350","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3390\/cells12141884","article-title":"A diagnostic gene-expression signature in fibroblasts of amyotrophic lateral sclerosis","volume":"12","author":"Morello","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2024.104138_b0355","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, and Parkinson\u2019s disease, Huntington\u2019s disease and Amyotrophic Lateral Sclerosis\u2014an updated review","volume":"71","author":"Alqahtani","year":"2023","journal-title":"Mitochondrion"},{"key":"10.1016\/j.drudis.2024.104138_b0360","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40035-022-00308-y","article-title":"The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders","volume":"11","author":"Olesen","year":"2022","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.drudis.2024.104138_b0365","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1242\/dmm.011007","article-title":"Preclinical research in Rett syndrome: setting the foundation for translational success","volume":"5","author":"Katz","year":"2012","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.drudis.2024.104138_b0370","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.drudis.2019.08.001","article-title":"A human-on-a-chip approach to tackling rare diseases","volume":"24","author":"de Mello","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2024.104138_b0375","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/s13023-023-02978-x","article-title":"Efficacy and safety of compassionate use for rare diseases: a scoping review from 1991 to 2022","volume":"18","author":"Wu","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.drudis.2024.104138_b0380","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/pro.3805","article-title":"Developments, applications, and prospects of cryo-electron microscopy","volume":"29","author":"Benjin","year":"2020","journal-title":"Protein Sci"},{"key":"10.1016\/j.drudis.2024.104138_b0385","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41592-023-02087-4","article-title":"AlphaFold predictions are valuable hypotheses and accelerate but do not replace experimental structure determination","volume":"21","author":"Terwilliger","year":"2024","journal-title":"Nat Methods"},{"key":"10.1016\/j.drudis.2024.104138_b0390","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41594-023-00941-9","article-title":"Mechanism of receptor assembly via the pleiotropic adipokine Leptin","volume":"30","author":"Tsirigotaki","year":"2023","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.drudis.2024.104138_b0395","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1172\/JCI40979","article-title":"Hereditary spastic paraplegia proteins REEP1, spastin, and atlastin-1 coordinate microtubule interactions with the tubular ER network","volume":"120","author":"Park","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2024.104138_b0400","doi-asserted-by":"crossref","first-page":"8981","DOI":"10.3390\/app11198981","article-title":"The development of microscopy for super-resolution: confocal microscopy, and image scanning microscopy","volume":"11","author":"Sheppard","year":"2021","journal-title":"Appl Sci"},{"key":"10.1016\/j.drudis.2024.104138_b0405","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf3928","article-title":"Increased spatiotemporal resolution reveals highly dynamic dense tubular matrices in the peripheral ER","volume":"354","author":"Nixon-Abell","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.drudis.2024.104138_b0410","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41467-023-44264-1","article-title":"High-content small molecule screen identifies a novel compound that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia","volume":"15","author":"Saffari","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2024.104138_b0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003988","article-title":"A hereditary spastic paraplegia mouse model supports a role of ZFYVE26\/SPASTIZIN for the endolysosomal system","volume":"9","author":"Khundadze","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.drudis.2024.104138_b0420","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vascn.2016.03.008","article-title":"The emerging role of in vitro electrophysiological methods in CNS safety pharmacology","volume":"81","author":"Accardi","year":"2016","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.drudis.2024.104138_b0425","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.875468","article-title":"Loss of ARHGAP15 affects the directional control of migrating interneurons in the embryonic cortex and increases susceptibility to epilepsy","volume":"10","author":"Liaci","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.drudis.2024.104138_b0430","series-title":"GeneReviews","article-title":"ALS2-related disorder","author":"Orrell","year":"1993"},{"key":"10.1016\/j.drudis.2024.104138_b0435","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng1001-166","article-title":"A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2","volume":"29","author":"Hadano","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.drudis.2024.104138_b0440","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood-brain barrier delivery","volume":"12","author":"Pardridge","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2024.104138_b0445","doi-asserted-by":"crossref","first-page":"16774","DOI":"10.1021\/acsomega.9b01512","article-title":"To pass or not to pass: predicting the blood-brain barrier permeability with the 3D-RISM-KH molecular solvation theory","volume":"4","author":"Roy","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.drudis.2024.104138_b0450","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2174\/138920008786485182","article-title":"Assays to predict drug permeation across the blood-brain barrier, and distribution to brain","volume":"9","author":"Abbott","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.drudis.2024.104138_b0455","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/0271678X16630991","article-title":"In vitro models of the blood-brain barrier: an overview of commonly used brain endothelial cell culture models and guidelines for their use","volume":"36","author":"Helms","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.drudis.2024.104138_b0460","doi-asserted-by":"crossref","first-page":"e38149","DOI":"10.1371\/journal.pone.0038149","article-title":"Transcriptional profiling of human brain endothelial cells reveals key properties crucial for predictive in vitro blood-brain barrier models","volume":"7","author":"Urich","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2024.104138_b0465","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.3390\/genes14091756","article-title":"Outcome measures and biomarkers for clinical trials in hereditary spastic paraplegia: a scoping review","volume":"14","author":"Siow","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.drudis.2024.104138_b0470","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.drudis.2024.104138_b0475","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2024.104138_b0480","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/hmg\/ddy156","article-title":"Impaired mitochondrial dynamics underlie axonal defects in hereditary spastic paraplegias","volume":"27","author":"Denton","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.drudis.2024.104138_b0485","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13578-022-00754-1","article-title":"Transcriptomic characterization of tissues from patients and subsequent pathway analyses reveal biological pathways that are implicated in spastic ataxia","volume":"12","author":"Kakouri","year":"2022","journal-title":"Cell Biosci"},{"key":"10.1016\/j.drudis.2024.104138_b0490","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1038\/s41467-023-42682-9","article-title":"Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis","volume":"14","author":"\u00c5kesson","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2024.104138_b0495","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/metabo12020174","article-title":"2-year-old and 3-year-old Italian ALS patients with novel ALS2 mutations: identification of key metabolites in their serum and plasma","volume":"12","author":"Gautam","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.drudis.2024.104138_b0500","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/01.WNL.0000048207.28790.25","article-title":"Infantile ascending hereditary spastic paralysis (IAHSP): clinical features in 11 families","volume":"60","author":"Lesca","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.drudis.2024.104138_b0505","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1086\/342359","article-title":"Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene","volume":"71","author":"Eymard-Pierre","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.drudis.2024.104138_b0510","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1093\/hmg\/ddw180","article-title":"Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice","volume":"25","author":"Hadano","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.drudis.2024.104138_b0515","doi-asserted-by":"crossref","first-page":"17135","DOI":"10.1074\/jbc.RA118.003849","article-title":"Altered oligomeric states in pathogenic ALS2 variants associated with juvenile motor neuron diseases cause loss of ALS2-mediated endosomal function","volume":"293","author":"Sato","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2024.104138_b0520","doi-asserted-by":"crossref","first-page":"e32282","DOI":"10.7554\/eLife.32282","article-title":"Rab5 and Alsin regulate stress-activated cytoprotective signaling on mitochondria","volume":"7","author":"Hsu","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.drudis.2024.104138_b0525","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1093\/emboj\/20.22.6265","article-title":"Functional and physical interactions of the adaptor protein complex AP-4 with ADP-ribosylation factors (ARFs)","volume":"20","author":"Boehm","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.drudis.2024.104138_b0530","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/pro.3870","article-title":"Integrating structural and evolutionary data to interpret variation and pathogenicity in adapter protein complex 4","volume":"29","author":"Gadbery","year":"2020","journal-title":"Protein Sci"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624002630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624002630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:32:55Z","timestamp":1755649975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644624002630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":106,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1359644624002630"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2024.104138","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical alternative drug discovery programs for monogenic rare diseases. Should small molecules or gene therapy be used? The case of hereditary spastic paraplegias","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2024.104138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104138"}}